Heptane-1,1-diamine | 64012-50-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Heptane-1,1-diamine
• CAS: 64012-50-6
• 化学式: C₇H₁₈N₂
• 分子量: 130.23
• InChiKey: IZKZIDXHCDIZKY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  9
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  52
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• Polymeric coupling agents and pharmaceutically-active polymers made therefrom
  申请人：Santerre J. Paul

  公开号：US20050255082A1

  公开（公告）日：2005-11-17

  A pharmaceutically-active polymeric compound of the general formula (I), Y-[Y n -LINK B-X] m -LINK B  (I) wherein (i) X is a coupled biological coupling agent of the general formula (II) Bio-LINK A-Bio  (II) wherein Bio is a biologically active agent fragment or precursor thereof linked to LINK A through a hydrolysable covalent bond; and LINK A is a coupled central flexible linear first segment of <2000 theoretical molecular weight linked to each of said Bio fragments; (ii) Y is LINK B-OLIGO; wherein (a) LINK B is a coupled second segment linking one OLIGO to another OLIGO and an OLIGO to X or precursor thereof; and (b) OLIGO is a short length of polymer segment having a molecular weight of less than 5,000 and comprising less than 100 monomeric repeating units; (iii) m is 1-40; and (iv) n is selected from 2-50. The compounds are useful as biomaterials, particularly, providing antibacterial activity in vivo. Also provided are biological coupling agents useful as intermediates in the preparation of the pharmaceutically-active polymeric compounds.

  一种具有一般式（I）的药用活性聚合物化合物， Y-[Y n -LINK B-X] m -LINK B  （I） 其中（i）X是一种偶联的生物偶联剂，具有一般式（II） Bio-LINK A-Bio  （II） 其中Bio是与LINK A通过可水解共价键连接的生物活性剂片段或其前体；而LINK A是与每个Bio片段连接的理论分子量小于2000的偶联中心柔性线性第一段；（ii）Y是LINK B-OLIGO；其中（a）LINK B是将一个OLIGO与另一个OLIGO以及一个OLIGO与X或其前体连接的偶联的第二段；（b）OLIGO是具有分子量小于5,000且包含少于100个单体重复单元的短聚合物段；（iii）m为1-40；（iv）n从2-50中选择。这些化合物可用作生物材料，特别是在体内提供抗菌活性。还提供了作为药用活性聚合物化合物制备中间体的生物偶联剂。
• BIODEGRADABLE HYBRID POLYMERS USABLE IN MEDICAL TECHNOLOGY OR IN BIOLOGY, STARTING SILANES THEREFOR, AND PREPARATION PROCESS THEREFOR AND USES THEREOF
  申请人：Fraunhofer-Gesellschaft Zur Forderung der Angewandten Forschung E.V.

  公开号：US20170313726A1

  公开（公告）日：2017-11-02

  The invention relates to a silane or silane mixture obtainable by reacting a hydrolysable silane of the formula (A): SiR4 in which R is a hydrolytically condensable group or hydroxyl with a compound R*(OH)x where x is 1, 2, 3 or greater 3, where R* has a straight-chain or branched hydrocarbon skeleton which, according to the number x, is monovalent, divalent, trivalent or multivalent, and has a hydrocarbonaceous chain interrupted by at least two —C(O)O— groups, wherein there are a maximum of 8 successive carbon atoms in the individual hydrocarbon units formed by interruptions within this chain and the, or in the case of branched structures at least one, end of the hydrocarbonaceous chain at the opposite end to the sole hydroxyl group or one of the hydroxyl groups bears an organically polymerizable group, wherein the alcohol is otherwise unsubstituted or has further substituents. The invention further relates to an organically modified silica polycondensate formed as a result of hydrolytic condensation of the silane or silane mixture and optionally a subsequent organic polymerization of the organically polymerizable groups, with optional addition of an organic, at least difunctional compound to the silica polycondensate prior to the organic polymerization.

  该发明涉及一种硅烷或硅烷混合物，其可通过将具有以下式(A)的可水解硅烷与化合物R*(OH)x反应而得到：SiR4，其中R是一个可水解缩聚基团或羟基，化合物R*具有直链或支链烃骨架，根据数目x，该骨架是一价、二价、三价或多价的，并且具有至少两个—C(O)O—基团中断的烃链，其中在该链内由中断形成的各个烃单元中最多有8个连续的碳原子，或者在支链结构的情况下，至少有一个烃链的末端，与唯一的羟基或其中一个羟基相对的末端具有一个有机聚合基团，其中醇在其他方面未被取代或具有进一步的取代基。该发明还涉及一种有机改性的二氧化硅缩聚物，其是由硅烷或硅烷混合物的水解缩聚以及有机聚合基团的随后有机聚合形成的，有机聚合之前在有机聚合之前向二氧化硅缩聚物中添加有机的至少二官能化合物。
• COMPOUNDS AND COMPOSITIONS FOR DRUG RELEASE
  申请人：INTERFACE BIOLOGICS, INC.

  公开号：US20160038651A1

  公开（公告）日：2016-02-11

  The invention relates to compounds that include biologically active agents (e.g., compounds according to any of formulas (I) and (I-A) that can be used for effective drug release, e.g., as coatings for medical devices. Use of these compounds in the coating of surfaces can allow for long-term drug release as well as imparting uniform coatings with little phase separation compared to, e.g., the parent biologically active agent.

  这项发明涉及包括生物活性剂（例如，根据任何公式（I）和（I-A）的化合物）的化合物，可用作有效的药物释放，例如，作为医疗器械的涂层。在表面涂层中使用这些化合物可以实现长期药物释放，并且与原生生物活性剂相比，可以实现均匀涂层且几乎没有相分离。
• Synthesis of polyphosphazenes with sulfonimide side groups
  申请人：The Penn State Research Foundation

  公开号：US20040225153A1

  公开（公告）日：2004-11-11

  The invention relates to sulfonimide bearing phenolic compounds and the use of those compounds to produce polyphosphazenes functionalized by one or more of those compounds alone, or in combination with cosubstituents. The invention also relates to blends of sulfonimide functionalized phosphazene polymers with other polymers, membranes formed of the functionalized polymers, and the use of those membranes in devices such as fuel cells.

  这项发明涉及含有磺酰胺基酚类化合物，以及利用这些化合物单独或与共取代基组合来生产官能化为一种或多种磺酰胺基酚类化合物的聚磷氮酸酯。该发明还涉及磺酰胺基磷氮酸酯聚合物与其他聚合物的混合物，由官能化聚合物形成的膜，以及将这些膜用于燃料电池等设备的用途。
• [EN] MELAMPOMAGNOLIDE B DIMERS<br/>[FR] DIMÈRES DE MÉLAMPOMAGNOLIDE B
  申请人：UNIV ARKANSAS

  公开号：WO2016090166A1

  公开（公告）日：2016-06-09

  The present disclosure provides dimers of melampomagnolide B (MMB), including carbamate, carbonate, succinic amide, ester and carboxamide dimers of MMB. These derivatives are useful for treating cancer in humans, in particular in treating leukemia, including acute myelogenous leukemia (AML). A compound comprising Formula (1 ) wherein: Z is independently selected from the group consisting of CH2, O, C(O), and CH, wherein when Z is CH, Z is connected to Y via a double bond and Y is N.

  本公开提供了美拉波木内酯B（MMB）的二聚体，包括MMB的氨基甲酸酯、碳酸酯、琥珀酰胺、酯和羧酰胺二聚体。这些衍生物对于治疗人类癌症特别有用，尤其是治疗白血病，包括急性髓性白血病（AML）。一种包含如下式（1）的化合物：其中：Z独立地选自由CH2、O、C（O）和CH组成的群，当Z为CH时，Z通过双键连接到Y，而Y为N。